Acylation stimulating protein: A female lipogenic factor?

Obesity Reviews

Volumn 12, Issue 6, 2011, Pages 440-448

  Saleh, J ^a   Al Wardy, N ^a   Farhan, H ^a   Al Khanbashi, M ^a   Cianflone, K ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

ASP; Females; Lipogenesis; Subcutaneous

Indexed keywords

ACYLATION STIMULATING PROTEIN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FATTY ACID SYNTHASE; PROGESTERONE; TESTOSTERONE; TRIACYLGLYCEROL;

ACYLATION; ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; BINDING AFFINITY; BIRTH WEIGHT; BODY FAT DISTRIBUTION; BODY MASS; CELL MEMBRANE; ENERGY EXPENDITURE; HUMAN; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MENSTRUAL CYCLE; NONHUMAN; OBESITY; POSTMENOPAUSE; POSTPRANDIAL STATE; PREGNANCY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ACYLATION; ADIPOCYTES; ANIMALS; FEMALE; GONADAL STEROID HORMONES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOGENESIS; MALE; MICE; POSTPRANDIAL PERIOD; SEX FACTORS; SUBCUTANEOUS FAT, ABDOMINAL; TRIGLYCERIDES; WEIGHT GAIN;

EID: 79956276669     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2010.00832.x     Document Type: Article

References (88)

1. Cianflone K, Sniderman AD, Walsh M, Vu H, Gagnon J, Rodriguez MA. Purification and characterization of acylation stimulating protein. J Biol Chem 1989; 264: 426-430.
2. Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K. The f-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993; 92: 1543-1547.
3. Cianflone K, Maslowska M, Sniderman AD. Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Semin Cell Dev Biol 1999; 10: 31-41.
4. Tao YZ, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta 1997; 1344: 221-229.
5. Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes 1997; 21: 261-266.
6. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991; 26: 495-499.
7. Faraj M, Sniderman AD, Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res 2004; 45: 657-666.
8. Van Harmelen V, Reynisdottir S, Cianflone K, Degerman E, Hoffstedt J, Nilsell K, Sniderman A, Arner P. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation stimulating protein and insulin. J Biol Chem 1999; 274: 18243-18251.
9. Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 2005; 280: 23936-22394.
10. Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/ acylation stimulating protein. J Biol Chem 2003; 278: 11123-11129.
11. Baldo A, Sniderman ADS, Luce S, Zhang XJ, Cianflone K. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res 1995; 36: 1415-1426.
12. Maslowska M, Legakis H, Assadi F, Cianflone K. Targeting the signaling pathway of acylation stimulating protein. J Lipid Res 2006; 47: 643-652.
13. Cianflone K, Vu H, Walsh M, Baldo A, Sniderman AD. Metabolic response of acylation stimulating protein to an oral fat load. J Lipid Res 1989; 30: 1727-1733.
14. Charlesworth J, Peake P, Campbell L, Pussell B, O'Grady S, Tzilopoulos T. The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers. Int J Obes 1998; 22: 1096 -1102.
15. Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998; 39: 884-891.
16. Maslowska M, Vu H, Sniderman AD. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999; 29: 679-686.
17. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 2003; 1609: 127-143.
18. Cianflone K, Roncari D, Maslowska M, Baldo A, Forden J, Sniderman AD. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994; 33: 9489-9495.
19. Sniderman AD, Cianflone K, Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obes 1991; 15: 333-336.
20. Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 1594-1602.
21. Cianflone K, Kalant D, Marliss EB, Gougeon R, Sniderman AD. Response of plasma ASP to a prolonged fast. Int J Obes Relat Metab Disord 1995; 19: 604-609.
22. Tahiri Y, Karpe F, Tan Garry D, Cianflone K. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab 2007; 4: 11.
23. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 2001; 21: 1034-1039.
24. Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K. Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. Int J Obes 2006; 30: 439-446.
25. Ozata M, Oktenli C, Gulec M, Ozgurtas T, Bulucu F, Caglar K, Bingol N, Vural A, Ozdemir IC. Increased fasting plasma acylation-stimulating protein concentrations in nephrotic syndrome. J Clin Endocrinol Metab 2002; 87: 853-858.
26. Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K. Increased acylation stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 2009; 91: 213-219.
27. Oktenli C, Ozgurtas T, Dede M, Sanisoglu Y, Yenen M, Yesilova Z, Kenar L, Kurt Y, Baser I, Smith J, Cianflone K. Metformin decreases circulating acylation stimulating protein levels in polycystic ovary syndrome. Gynecol Endocrinol 2007; 23: 710-715.
28. Cianflone K, Zhang XJ, Genest J, Sniderman AD. Plasma acylation stimulating protein in coronary artery disease. Arterioscler Tromb Vasc Biol 1997; 17: 1239-1244.
29. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000; 141: 1041-1049.
30. Murray I, Sniderman AD, Cianflone K. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J Lipid Res 1999; 40: 1671-1676.
31. Zhang XJ, Cianflone K, Genest J, Sniderman AD. Plasma ASP as a predictor of impaired cellular biologic response to ASP in patients with hyperapoB. Eur J Clin Invest 1998; 28: 730-739.
32. Cianflone K, Maslowska M, Sniderman AD. Impaired Response of Fibroblasts from Patients with Hyperapobetalipoproteinemia to Acylation-stimulating Protein. J Clin Invest 1990; 85: 722-730.
33. Wen Y, Wang H, MacLaren R, Wu J, Lu H, Cianflone K. Palmitate and oleate induction of acylation stimulating protein resistance in 3t3-l1 adipocytes and preadipocytes. J Cell Biochem 2007; 104: 391- 401.
34. Wen Y, Wang H, MacLaren R, Lu H, Hu XF, Cianflone K. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes. J Cell Biochem 2008; 105: 404-413.
35. Wajchenberg B. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
36. Gallagher D, Heymsfield S, Heo M, Jebb S, Murgatroyd P, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000; 72: 694-701.
37. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després J. Gender difference in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999; 19: 2448-2455.
38. Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol Endocrinol Metab 1993; 265: E374-E379.
39. Maslowska M, Sniderman AD, MacLean LD, Cianflone K. Regional differences in triacylglycerol synthesis in adipose tissue. J Lipid Res 1993; 34: 219-228.
40. Pasasoǧlu H, Muhtaroǧlu S, Ünal A, Yiǧitbasi T. The reference values of apolipoprotein B related with age and sex. Turk J Med Res 1995; 13: 151-153.
41. Gardner CD, Tribble DL, Young DR, Ahn D, Fortmann SP. Population frequency distributions of HDL, HDL2, and HDL3 cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford five city project source. Prev Med 2000; 31: 335-345.
42. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004; 5: 197-216.
43. Cooke PS, Naaz A. Role of estrogens in adipocyte development and function. Exp Biol Med 2004; 229: 1127-1135.
44. Pedersen SB, Bruun JM, Hube F, Kristensen K, Hauner H, Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 2001; 182: 27-37.
45. Homma H, Kurachi H, Nishio Y, Takeda T, Yamamoto T, Adachi K, Morishige K, Ohmichi M, Matsuzawa Y, Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. J Biol Chem 2000; 275: 11404-11411.
46. D'Eon T, Souza S, Aronovitz M, Obin M, Fried S, Greenberg A. Estrogen regulation of adiposity and fuel partitioning. J Biol Chem 2005; 280: 35983-35991.
47. Plain S, Mc Ternan P, Anderson L, Sturdee D, Barnett A, Kumar S. 17-Beta-estradiol and anti-estrogen ICI: compound 182780 regulate expression of lipoprotein lipase and hormone sensitive lipase in isolated subcutaneous abdominal adipocytes. Meatbolism 2003; 52: 383-388.
48. Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 2001; 288: 191-197.
49. Monjo M, Rodrígue AM, Palou A, Roca P. Direct effects of testosterone, 17β- Estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis. Endocrinology 2003; 144: 4923-4930.
50. Gonzalez C, Alonso A, Alvarez N, Diaz F, Martinez M, Fernandez S, Patterson AM. Role of 17beta-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy. J Endocrinol 2000; 166: 283-291.
51. Pedersen S, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating α2A- adrenergic receptors directly in human adipose tissue through estrogen receptor α. Implications for the female fat distribution. J Clin Endocrinol Metab 2002; 89: 1869-1878.
52. Jones ME, Thorburn AW, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A 2000; 97: 12735-12740.
53. Andersson T, Söderström I, Simonyté K, Olsson T. Estrogen reduces 11β-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats obesity. 2010; 18: 470-475. doi:10.1038/oby.2009.294.
54. Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol 1982; 142: 735-738.
55. O'Brien S, Welter B, Mantzke K, Price T. Identification of progesterone receptor in human subcutaneous adipose tissue. J Clin Endocrinol Metab 1998; 83: 509-513.
56. Gray JM, Wade GN. Cytoplasmic estrogen, but not progestin, binding sites in male rat adipose tissues. Am J Physiol 1980; 239: E237-E241.
57. Gray JM, Wade GN. Cytoplasmic progestin binding in rat adipose tissues. Endocrinology 1979; 104: 1377-1382.
58. Pedersen S, Kristensen K, Richelsen B. Anti glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism. Steroids 2003; 68: 543-550.
59. Lacasa D, Liepvre X, Ferre P, Dugail I. Progesterone stimulates adipocyte determination and differentiation1/sterol regulatory element-binding protein 1c gene expression. J Biol Chem 2001; 276: 11512-11516.
60. Björntrop P. Hormonal control of regional fat distribution. Hum Reprod 1997; 12: 21-25.
61. Marin P, Oden B, Björntrop P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995; 80: 239-243.
62. Marin P, Lonn L, Andersson B, Oden B, Olbe L, Bengtsson BA, Björntrop P. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab 1996; 81: 1018-1022.
63. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001; 86: 724-731.
64. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40: 1323-1326.
65. Saleh J, Christou N, Cianflone K. Regional specificity of ASP binding in human adipose tissue. Am J Physiol Endocrinol Metab 1999; 276: E815-E821.
66. Wamba PC, Mi J, Zhao XY, Zhang MX, Wen Y, Cheng H, Hou DQ, Cianflone K. Acylation stimulating protein but not complement C3 associates with metabolic syndrome components in Chinese children and adolescents. Eur J Endocrinol 2008; 159: 781-790.
67. Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman AD. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 2004; 45: 124-131.
68. Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Volta U, Puddu GM, Puddu P. Relationship between serum levels and traditional risk factors for myocardial infarction. Acta Cardiologica 1998; 53: 345-354.
69. Muscari A, Antonelli S, Bianchi G, Cavrini C, Dapporto S, Ligabue A, Ludovico C, Magalotti D, Poggiopollini G, Zoli M. on behalf of the Pianoro Study Group. Serum C3 s a stronger inflammatory marker of insulin resistance than CReactive protein, Leukocyte count, and erythrocyte sedimentation rate. Diabetes Care 2007; 30: 2362-2368.
70. Linder K, Arner P, Flores-Morales A, Tollet-Egnell P, Norstedt G. Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women. J Lipid Res 2004; 45: 148-154.
71. Saleh J, Al-Khanbashi M, Al-Maarof M, Al-Lawati M, Rizvi SG, Cianflone K. Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle. Eur J Endocrinol 2009; 160: 301-307.
72. Sodowski K, Zwirska-Korczala K, Kuka D, Kukla M, Budziszewska P, Zebaty A, Wender-Ozegowska E, Wloch A. Acylation stimulating protein is associated with pregnancy weight gain. J Physiol Pharmacol 2008; 59: 33-43.
73. Saleh J, Cianflone K, Chaudhary TA, Al-Riyami H, Al-Abri A, Bayoumi R. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity 2007; 15: 646-652.
74. Hasty LA, Brockman WW, Lambris JD, Lyttle CR. Hormonal regulation of complement factor b in human endometrium. Am J Reprod Immunol 1993; 30: 63-67.
75. Norton M, Buchanan TA, Kitzmiller J. Endocrine pancreas and maternal metabolism. In: Tulchinsky D, Little BA (eds). Maternal-Fetal Endocrinology, 2nd edn. WB Saunders Company: Philadelphia, PA, 1994, pp. 48-77.
76. O'Sullivan A, Martin A, Brown MA. Efficient fat storage in premenopausal women and in early pregnancy: a role for estrogen. J Clin Endocrinol Metab 2001; 86: 4951-4956.
77. Shao J, Qiao L, Friedman JE. Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 β-cells. Am J Physiol Endocrinol Metab 2004; 286: E304-E310.
78. Saleh J, Al-Riyami HD, Chaudhary TA, Cianflone K. Cord blood ASP is predicted by maternal lipids and correlates with fetal birth weight. Obesity (Silver Spring) 2008; 16: 1193-1198.
79. Jovanovic L, Knopp RH, Brown Z, Conley MR, Park E, Mills JL, Metzger BE, Aarons JH, Holmes LB, Simpson JL. Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 2001; 24: 1130-1136.
80. Li SH, Huang HL, Chen YH. Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period. Biol Reprod 2002; 66: 322-332.
81. Fan JD, Wagner BL, McDonnell DP. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 1996; 10: 1605-1616.
82. Georgopoulos A, Rosengard AM. Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: effects of gender. Metabolism 1989; 38: 781-789.
83. Scantlebury-Manning T, Bower J, Cianflone K, Barakat H. Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women. Nutr Metab 2009; 6: 18.
84. Maedas N, Li H, Lee D, Oliver P, Quarfordtg SH, Osadan J. Targeted disruption of the apolipoprotein (2-111) gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem 1994; 269: 23610-23616.
85. Lemonnier D. Effect of age, sex, and site on the cellularity of the adipose tissue in mice and rats rendered obese by a high-fat diet. J Clin Invest 1972; 51: 2907-2915.
86. Jesmok GJ, Woods EF, Ditzler WS, Walsh G. Fat Emulsion Catabolism in vitro and in vivo - sex related differences. JPEN J Parenter Enteral Nutr 1981; 5: 200-203.
87. Moller DE, Chang PY, Yaspelkis BB, Flier JS, Wallberg- Hendriksson H, Ivy JL. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. Endocrinology 1996; 137: 2397-2405.
88. Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie AD. Interaction between BTBR and C57BL/6J genomes produces an Insulin resistance syndrome in (BTBR x C57BL/6J) F1 mice. Arterioscl Thromb Vasc Biol 1997; 17: 3286-3293.